Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
BANTAM-01: A Multicenter, Open-Label, First-in-Human Phase 1 Dose Escalation and Expansion Study of 225Ac-GPC3 (BAY 3547926) in Patients with Advanced Hepatocellular Carcinoma.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 09, 2025
BANTAM-01: A Multicenter, Open-Label, First-in-Human Phase 1 Dose Escalation and Expansion Study of 225Ac-GPC3 (BAY 3547926) in Patients with Advanced Hepatocellular Carcinoma.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 09, 2025
Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer.
Journal: Anesthesia and analgesia
Published: October 18, 2011
Showing 1-3 of 3
Last Updated: 09/26/2026